X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs NATCO PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE NATCO PHARMA CADILA HEALTHCARE/
NATCO PHARMA
 
P/E (TTM) x 32.7 30.8 105.9% View Chart
P/BV x 6.5 23.4 27.7% View Chart
Dividend Yield % 0.7 0.5 148.5%  

Financials

 CADILA HEALTHCARE   NATCO PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
NATCO PHARMA
Mar-14
CADILA HEALTHCARE/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs460877 52.5%   
Low Rs305424 72.0%   
Sales per share (Unadj.) Rs92.1223.4 41.2%  
Earnings per share (Unadj.) Rs14.831.1 47.7%  
Cash flow per share (Unadj.) Rs18.540.3 45.9%  
Dividends per share (Unadj.) Rs3.205.00 64.0%  
Dividend yield (eoy) %0.80.8 108.8%  
Book value per share (Unadj.) Rs68.0219.5 31.0%  
Shares outstanding (eoy) m1,023.7433.07 3,095.7%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x4.22.9 142.7%   
Avg P/E ratio x25.820.9 123.3%  
P/CF ratio (eoy) x20.716.1 128.2%  
Price / Book Value ratio x5.63.0 189.9%  
Dividend payout %21.616.1 134.2%   
Avg Mkt Cap Rs m391,58121,504 1,821.0%   
No. of employees `00016.9NA-   
Total wages/salary Rs m15,0021,128 1,330.3%   
Avg. sales/employee Rs Th5,594.5NM-  
Avg. wages/employee Rs Th890.1NM-  
Avg. net profit/employee Rs Th899.9NM-  
INCOME DATA
Net Sales Rs m94,2957,389 1,276.2%  
Other income Rs m1,286167 769.6%   
Total revenues Rs m95,5817,556 1,265.0%   
Gross profit Rs m19,0361,793 1,061.5%  
Depreciation Rs m3,750304 1,231.9%   
Interest Rs m450366 122.9%   
Profit before tax Rs m16,1221,290 1,250.0%   
Minority Interest Rs m33846 730.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,289309 417.6%   
Profit after tax Rs m15,1681,027 1,476.3%  
Gross profit margin %20.224.3 83.2%  
Effective tax rate %8.023.9 33.4%   
Net profit margin %16.113.9 115.7%  
BALANCE SHEET DATA
Current assets Rs m60,2233,681 1,635.9%   
Current liabilities Rs m53,0583,123 1,699.1%   
Net working cap to sales %7.67.6 100.5%  
Current ratio x1.11.2 96.3%  
Inventory Days Days7089 78.0%  
Debtors Days Days8859 150.2%  
Net fixed assets Rs m72,9847,685 949.7%   
Share capital Rs m1,024331 309.6%   
"Free" reserves Rs m68,5766,670 1,028.2%   
Net worth Rs m69,6007,259 958.8%   
Long term debt Rs m24,684955 2,585.0%   
Total assets Rs m152,20711,957 1,272.9%  
Interest coverage x36.84.5 814.4%   
Debt to equity ratio x0.40.1 269.6%  
Sales to assets ratio x0.60.6 100.3%   
Return on assets %10.311.7 88.0%  
Return on equity %21.814.2 154.0%  
Return on capital %17.920.7 86.5%  
Exports to sales %039.4 0.0%   
Imports to sales %05.7 0.0%   
Exports (fob) Rs mNA2,908 0.0%   
Imports (cif) Rs mNA421 0.0%   
Fx inflow Rs m21,2803,445 617.6%   
Fx outflow Rs m10,874703 1,547.2%   
Net fx Rs m10,4062,743 379.4%   
CASH FLOW
From Operations Rs m13,4951,440 937.0%  
From Investments Rs m-29,103-1,089 2,672.0%  
From Financial Activity Rs m23,158-353 -6,565.9%  
Net Cashflow Rs m7,556-1 -507,114.1%  

Share Holding

Indian Promoters % 74.8 52.0 143.7%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 8.3 7.8 105.9%  
FIIs % 5.9 16.6 35.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 26.0 42.3%  
Shareholders   44,069 25,395 173.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   WYETH LTD  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Above 35,000 Mark; Bank & IT Stocks Outperform(Closing)

After opening the day flat, share markets in India witnessed positive trading activity throughout the day and ended the day on a strong note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 17, 2018 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - AJANTA PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS